Orion Oyj (OTCMKTS:ORINF) Sees Large Decline in Short Interest

Orion Oyj (OTCMKTS:ORINF) was the recipient of a large decrease in short interest during the month of March. As of March 15th, there was short interest totalling 283,700 shares, a decrease of 54.5% from the February 28th total of 623,300 shares. Based on an average trading volume of 100 shares, the days-to-cover ratio is presently 2,837.0 days.

Orion Oyj Stock Performance

Shares of OTCMKTS:ORINF remained flat at $48.65 during mid-day trading on Friday. Orion Oyj has a one year low of $48.65 and a one year high of $48.65. The company has a 50 day moving average price of $48.65 and a 200 day moving average price of $48.07.

Orion Oyj Company Profile

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson’s disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer.